155 related articles for article (PubMed ID: 15762285)
21. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
Chen DB; Wang Y; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829
[TBL] [Abstract][Full Text] [Related]
22. Role of Epstein-Barr virus status and immunophenotypic studies in the evaluation of exfoliative cytology specimens from patients with post-transplant lymphoproliferative disorders.
Gibson SE; Picarsic J; Swerdlow SH; Pantanowitz L
Cancer Cytopathol; 2016 Jun; 124(6):425-35. PubMed ID: 26992116
[TBL] [Abstract][Full Text] [Related]
23. Posttransplant Lymphoproliferative Disorder in Solid Organ and Hematopoietic Stem Cell Transplantation.
Nagle SJ; Reshef R; Tsai DE
Clin Chest Med; 2017 Dec; 38(4):771-783. PubMed ID: 29128025
[TBL] [Abstract][Full Text] [Related]
24. Is there a difference in post-transplant lymphoproliferative disorder in adults after solid organ and haematologic stem cell transplantation? Experience in 41 patients.
Tai R; Tirumani SH; Tirumani H; Shinagare AB; Hornick JL; Ramaiya NH
Br J Radiol; 2015 Aug; 88(1052):20140861. PubMed ID: 25989696
[TBL] [Abstract][Full Text] [Related]
25. Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop.
Harris NL; Ferry JA; Swerdlow SH
Semin Diagn Pathol; 1997 Feb; 14(1):8-14. PubMed ID: 9044505
[TBL] [Abstract][Full Text] [Related]
26. Donor or recipient origin of posttransplant lymphoproliferative disorders following solid organ transplantation.
Kinch A; Cavelier L; Bengtsson M; Baecklund E; Enblad G; Backlin C; Thunberg U; Sundström C; Pauksens K
Am J Transplant; 2014 Dec; 14(12):2838-45. PubMed ID: 25307322
[TBL] [Abstract][Full Text] [Related]
27. Pathologic and clinical features of Hodgkin lymphoma--like posttransplant lymphoproliferative disease.
Krishnamurthy S; Hassan A; Frater JL; Paessler ME; Kreisel FH
Int J Surg Pathol; 2010 Aug; 18(4):278-85. PubMed ID: 19578050
[TBL] [Abstract][Full Text] [Related]
28. Post-transplant lymphoproliferative disorders: role of viral infection, genetic lesions and antigen stimulation in the pathogenesis of the disease.
Capello D; Gaidano G
Mediterr J Hematol Infect Dis; 2009 Dec; 1(2):e2009018. PubMed ID: 21416004
[TBL] [Abstract][Full Text] [Related]
29. The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach.
Nalesnik MA
Transpl Infect Dis; 2001 Jun; 3(2):88-96. PubMed ID: 11395974
[TBL] [Abstract][Full Text] [Related]
30. B-cell posttransplant lymphoproliferative disorder isolated to the central nervous system is Epstein-Barr virus positive and lacks p53 and Myc expression by immunohistochemistry.
Sundin A; Grzywacz BJ; Yohe S; Linden MA; Courville EL
Hum Pathol; 2017 Mar; 61():140-147. PubMed ID: 27993575
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility-weighted imaging and diffusion-weighted imaging findings in central nervous system monomorphic B cell post-transplant lymphoproliferative disorder before and after treatment and comparison with primary B cell central nervous system lymphoma.
Ginat DT; Purakal A; Pytel P
J Neurooncol; 2015 Nov; 125(2):297-305. PubMed ID: 26341369
[TBL] [Abstract][Full Text] [Related]
32. The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients.
Wareham NE; Mocroft A; Sengeløv H; Da Cunha-Bang C; Gustafsson F; Heilmann C; Iversen M; Kirkby NS; Rasmussen A; Sørensen SS; Lundgren JD;
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1569-1580. PubMed ID: 29804164
[TBL] [Abstract][Full Text] [Related]
33. Impact of the posttransplant lymphoproliferative disorder subtype on survival.
Koff JL; Li JX; Zhang X; Switchenko JM; Flowers CR; Waller EK
Cancer; 2018 Jun; 124(11):2327-2336. PubMed ID: 29579330
[TBL] [Abstract][Full Text] [Related]
34. CD20 expression predicts survival in paediatric post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation.
Orjuela MA; Alobeid B; Liu X; Siebert AL; Kott ER; Addonizio LJ; Morris E; Garvin JH; Lobritto SJ; Cairo MS
Br J Haematol; 2011 Mar; 152(6):733-42. PubMed ID: 21275950
[TBL] [Abstract][Full Text] [Related]
35. PD-L1 and PD1 expression in post-transplantation lymphoproliferative disease (PTLD) of childhood and adolescence: An inter- and intra-individual descriptive study covering the whole spectrum of PTLD categories.
Schiefer AI; Salzer E; Füreder A; Szepfalusi Z; Müller-Sacherer T; Huber WD; Michel-Behnke I; Lawitschka A; Pichler H; Mann G; Hutter C; Simonitsch-Klupp I; Attarbaschi A
Cancer Med; 2019 Aug; 8(10):4656-4668. PubMed ID: 31269329
[TBL] [Abstract][Full Text] [Related]
36. Post-transplantation lymphoproliferative disorder of the NK-cell type: a case report and review of the literature.
Hsi ED; Picken MM; Alkan S
Mod Pathol; 1998 May; 11(5):479-84. PubMed ID: 9619602
[TBL] [Abstract][Full Text] [Related]
37. Posttransplant lymphoproliferative disorder in pediatric patients.
Hussein K; Tiede C; Maecker-Kolhoff B; Kreipe H
Pathobiology; 2013; 80(6):289-96. PubMed ID: 24013821
[TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of post-transplant lymphoproliferative disorder after kidney transplantation versus hematopoietic stem cell transplantation.
Yoon JH; Lee S; Kim HJ; Lee JW; Min WS; Chung BH; Yang CW; Kim YS; Kim JI; Moon IS; Oh EJ; Park GS; Cho SG
Transpl Int; 2014 Jul; 27(7):721-32. PubMed ID: 24684689
[TBL] [Abstract][Full Text] [Related]
39. Post-transplant lymphoproliferative disorder of the adrenal gland after allogeneic hematopoietic stem cell transplantation: report of two cases and literature review.
Kasahara H; Mori T; Kato J; Koda Y; Kohashi S; Kikuchi T; Sakurai M; Yamane Y; Mikami S; Kameyama K; Takahashi Y; Okamoto S
Transpl Infect Dis; 2015 Dec; 17(6):909-14. PubMed ID: 26426682
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant.
Akar Özkan E; Özdemir BH; Yılmaz Akçay E; Terzi A; Karakuş S; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():183-7. PubMed ID: 25894151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]